GO
Loading...

We're Moving Away From Defensive Expensive: Pro

Thursday, 25 Apr 2013 | 2:00 AM ET

Michael Browne, fund manager at Martin Currie discusses why the earnings of big name stocks Santander, Unilever, AstraZeneca and British American Tobacco have been so disappointing.